nodes	percent_of_prediction	percent_of_DWPC	metapath
Stanozolol—Norethindrone—ALB—focal segmental glomerulosclerosis	0.4	0.4	CrCbGaD
Stanozolol—Methyltestosterone—ALB—focal segmental glomerulosclerosis	0.38	0.38	CrCbGaD
Stanozolol—Testosterone—ALB—focal segmental glomerulosclerosis	0.22	0.22	CrCbGaD
